SHARES NEWS & ANALYSIS
- AstraZeneca PLC (4)
- Vectura Group PLC (3)
- Dechra Pharmaceuticals PLC (2)
- EpiStem Holdings PLC (2)
- Hutchison China MediTech Ltd (2)
- Serica Energy PLC (2)
- GlaxoSmithKline PLC (2)
- Standard Chartered PLC (2)
- Genus PLC (2)
- Petrofac Ltd (1)
- Pharmaceuticals & Biotechnology (28)
- Mining (5)
- Support Services (3)
- Oil & Gas Producers (3)
- Banks (3)
- Food Producers (2)
- General Financial (2)
- Industrial Engineering (2)
- Travel & Leisure (2)
- Fixed Line Telecommunications (1)
21 May 2013TIP UPDATE: Vectura's prospects look solid with product launches next year, but in the meantime newsflow will be thin
20 May 2013RESULTS: Speciality pharmaceutical group BTG delivered a robust full-year performance - but there's still a wait ahead before regulatory newsflow...
28 March 2013RESULTS: Hutchison China MediTech is being buoyed by growing Chinese healthcare spending
27 March 2013RESULTS: Personalised medicine and diagnostics group, Epistem, is on the verge of launching its Genedrive diagnostic test - a product with significant...
News & Tips: AstraZeneca, Vodafone, Bloomsbury Publishing, PV Crystalox Solar, Next, Ted Baker, Vesuvius, Solo Oil, Aminex, Turbo Power Systems & more
21 March 2013Equities are off colour today
07 March 2013RESULTS: A lot depends on Futura Medical finding new licensing partners this year, but the company holds a weak hand
05 March 2013RESULTS: This year looks set to be a tougher one for Abcam than 2012 after enforced cuts in US research budgets
26 February 2013RESULTS: Dechra's operational problems are mainly related to its acquisition strategy and should correct themselves during the year
25 February 2013RESULTS: Livestock farming's problems were global last year and even Genus could not avoid the ensuing ill-effects
21 February 2013RESULTS: Animalcare's drive to improve its animal pharma business seems to be paying off as the company reports higher sales growth and better...
26 October 2012A summary of key company announcements expected in the coming week
22 October 2012RESULTS: e-Therapeutics is focusing its product pipeline on cancer drugs and boasts enough cash to last until mid-2014
16 October 2012RESULTS: The contract research market may be under pressure but Epistem is finding other ways of selling its diagnostic technology
News & Tips: Vectura, Electrocomponents, Amerisur, Bellzone Mining, G4S, Ophir, Tanfield, Software Radio Technology & more
28 September 2012Equities are showing signs of bouncing back
12 September 2012RESULTS: Sales pressure in its home markets has forced Alliance Pharma to look to Europe for potential leads on new acquisitions
News & Tips: Burberry, Raven Russia, Crystal Amber, SuperGroup, GlenStrata, Betfair, Reneuron & more
11 September 2012Equity markets are likely to remain in something of a holding pattern for the next day or so as investors await two key events
04 September 2012RESULTS: Porcine demand in Asia is breeding demand for Genus' breeding on-demand expertise
04 September 2012An expensive summer of acquisitions underlines how quickly Dechra intends to diversify its revenues
News & Tips: AstraZeneca, Serica Energy, San Leon, Cairn Energy, Quadrise, Range Resources, Red Emporer, G4S & more
28 August 2012Markets are off a little at the beginning of a very busy results week
20 August 2012August inertia combines with expectations of QE to keep traders sitting on last week's gains
16 August 2012RESULTS: The after-shocks of the Arab Spring have abated, for now, but Hikma's premium rating looks vulnerable to operational problems and any...
15 August 2012Is the ECB about to bite the bullet where Spain is concerned?
14 August 2012We're all poorer today following a steep rise in the CPI and a general house price fall.
13 August 2012Weak economic data from Japan sets the week off on a bum note...
01 August 2012RESULTS: Shire's operational results were solid enough, but the generic threat to its key portfolio of attention deficit drugs is undermining...
31 July 2012RESULTS: Hutchison China Meditech keeps meeting targets despite worries over China
26 July 2012RESULTS: There's a decent dividend yield on offer at AstraZeneca, but it is hard to see the shares making any progress in what is proving to be a...
25 July 2012TIP UPDATE: A generally tough economic environment, combined with austerity cuts to healthcare budgets means it is time to take profits on our successful...